EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Functional insulin receptors are selectively expressed on cns astrocytes






Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 581 12

Functional insulin receptors are selectively expressed on cns astrocytes

We sought to determine if functional insulin receptors are present on CNS astrocytes. Although CNS glycogen is located exclusively in astrocytes, the role of insulin in CNS glycogen metabolism has yet to be studied. We used a combination of immunocytochemical techniques to localize insulin receptors to astrocytes, and glycogen assay to determine if insulin receptors were functional. Transgenic mice expressing GFP in GFAP-expressing astrocytes allowed positive astrocytic identification. Insulin receptors were found to be present on astrocytes in two CNS areas; hippocampus and corpus callosum, but were not present on optic nerve astrocytes. A punctate pattern of staining was found suggesting localized expression of the receptor. We also stained for the insulin-sensitive glucose transporter, Glut-4. We found that Glut-4 transporter expression mirrored that of the insulin receptor, being present on astrocytes in the hippocampus, corpus callosum but not in the optic nerve. The function of the insulin receptor was studied by assaying whether incubation with insulin increased glycogen content. We found that in hippocampus and corpus callosum incubation in 1 muM insulin significantly increased glycogen content above control, but that in optic nerve there was no significant effect of insulin on glycogen content. We conclude that functional insulin receptors are selectively expressed on astrocytes in both gray and white matter CNS areas.


Accession: 034960734



Related references

Anguelova, E.; Beuvon, F.; Leonard, N.; Chaverot, N.; Varlet, P.; Couraud, P-O.; Daumas-Duport, C.; Cazaubon, S., 2005: Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas. Endothelin-1 (ET-1), a vasoactive and mitogenic peptide mainly produced by vascular endothelial cells, may be involved in the progression of several human tumors. Here, we present an immunohistochemical analysis of the expression pattern of ET-1 r...

Anguelova, E.; Beuvon, F.; Leonard, N.; Chaverot, N.; Varlet, P.; Couraud, P.O.; Daumas-Duport, C.; Cazaubon, S., 2005: Functional endothelin ETB receptors are selectively expressed in human oligodendrogliomas. Endothelin-1 (ET-1), a vasoactive and mitogenic peptide mainly produced by vascular endothelial cells, may be involved in the progression of several human tumors. Here, we present an immunohistochem\ical analysis of the expression pattern of ET-1...

Selkirk, J.V.; Nottebaum, L.M.; Lee, J.; Yang, W.; Foster, A.C.; Lechner, S.M., 2006: Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Using cAMP accumulation as a functional readout, we pharmacologically characterized the response of native melanocortin receptors in cultured rat astrocytes, and found this response to be mediated by the melanocortin 4 receptor (MC4R). Melancorti...

Li, G.; Barrett, E.J.; Wang, H.; Chai, W.; Liu, Z., 2005: Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. In muscle, physiologic hyperinsulinemia, presumably acting on endothelial cells ( ECs), dilates arterioles and regulates both total blood flow and capillary recruitment, which in turn influences glucose disposal. In cultured ECs, however, supraphy...

Freund, G.G.; Kulas, D.T.; Way, B.A.; Mooney, R.A., 1993: Functional insulin and IGF-1 receptors are preferentially expressed in multiple myeloma as compared to other B cell neoplasms. Laboratory Investigation 68(1): 90A

Pochet, R.; Philippeau, M., 2003: Calcium/zinc binding protein, s100a6 is selectively expressed in astrocytes along impaired axons from ALS rat model. We previously have shown that in both amyotrophic lateral sclerosis (ALS) mice model and human ALS patients, S100A6 (previuously named calcyclin), a Ca/Zn binding proteins is overexpressed in astrocytes specifically localized along impaired axons...

Ota, A.; Wilson, G.L.; Spilberg, O.; Pruss, R.; LeRoith, D., 1988: Functional insulin-like growth factor I receptors are expressed by neural-derived continuous cell lines. High affinity insulin-like growth factor I (IGF-I) receptors are expressed by two human neural derived cell lines, SK-N-SH and SK-N-MC. Specific [125I]IGF-I binding to crude membranes was 23.4% for SK-N-SH and 10.7% for SK-N-MC, with 50% inhibitio...

Freund, G.G.; Kulas, D.T.; Way, B.A.; Mooney, R.A., 1994: Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. While IGF-1 plays a role in early B-cell development, little is known of insulin and insulin-like growth factor-1 (IGF-1) action in post-marrow B-cells. Recently, our laboratory demonstrated that mouse and human multiple myeloma (MM) cell lines po...

Chisalita, I.; Arnqvist, H., 2003: Insulin-like growth factor-I receptors are more expressed than insulin receptors in human micro- and macrovascular endothelial cells. Diabetes 52(Supplement 1): A152

Lundby, A.; Bolvig, P.; Hegelund, A.Charlotte.; Hansen, B.F.; Worm, J.; L├╝tzen, A.; Billestrup, N.; Bonnesen, C.; Oleksiewicz, M.B., 2016: Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues. There is a medical need for new insulin analogues. Yet, molecular alterations to the insulin molecule can theoretically result in analogues with carcinogenic effects. Preclinical carcinogenicity risk assessment for insulin analogues rests to a lar...